Research News

10 July 2024

Nerve damage from cancer treatment can be predicted

Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at LiU have developed a tool that can predict the risk level for each individual. The tool could help doctors adapt treatment to avoid persistent side effects in those at the greatest risk.

6 July 2024

Drugs that kill zombie cells may benefit some older women, but not all, Mayo Clinic study finds

Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a one-size-fits-all remedy, Mayo Clinic researchers have found. Specifically, these drugs may only benefit people with a high number of senescent cells, according to findings published today in Nature Medicine.

6 July 2024

Low-dose aspirin could help prevent pregnancy complications caused by flu infections

A world-first study has found low-dose aspirin may treat flu-induced blood vessel inflammation, creating better blood flow to the placenta during pregnancy.

1 July 2024

Breakthrough research makes cancer-fighting viral agent more effective

Researchers from Aarhus University have made a significant breakthrough by discovering that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.

1 July 2024

Study reveals why AI models that analyze medical images can be biased

Artificial intelligence models often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. However, studies have found that these models don’t always perform well across all demographic groups, usually faring worse on women and people of color.

27 June 2024

New Approach Accurately Identifies Medications Most Toxic to the Liver

The current method for assessing medication-related liver injury is not providing an accurate picture of some medications toxicity or lack thereof to the liver, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Classification of a medication’s potential to damage the liver, termed hepatotoxicity, has been historically determined by counting individual reported cases of acute liver injury

27 June 2024

New study demonstrates the efficacy of a promising celiac disease drug at the molecular level

A recent study led by researchers at Tampere University investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase 2 inhibitor prevents gluten-induced intestinal damage. The results of the new study, based on an analysis of the molecular activity of more than 10,000 genes, provide very strong evidence that the first successful drug to treat celiac disease may be at hand.

17 June 2024

New and crucial role discovered for a protein in the body's immunity against cancer

Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein traditionally known to prevent damage to the body's cells and tissues, plays a critical role in the immune system's defence against cancer. The findings of the study could improve the effectiveness of current cancer immunotherapies.

12 June 2024

Risk of death from COVID-19 lessens, but infection still can cause issues 3 years later

New findings on long COVID long-term effects on health experienced by many who have had COVID-19 present a good-news, bad-news situation, according to a study at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system.

12 June 2024

Researchers take step toward development of universal COVID-19 antibodies

SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at Texas Biomedical Research Institute (Texas Biomed), the University of Alabama at Birmingham (UAB) and Columbia University have developed a promising new human monoclonal antibody that appears a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2.

Search

Nerve damage from cancer treatment can be predicted

RECOMMENDED POSTS

Subscribe with us

Jobs by Category